Pulmatrix Corporate Overview - NASDAQ PULM

Pulmatrix is a clinical-stage biopharmaceutical company developing inhalation-based therapeutics, with focus on PUR3100 and pipeline candidates PUR1900 and PUR1800. The presentation covers clinical data, market opportunity, and risk profile for their investigational drug programs.